A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC

Status unconfirmed

Conditions studied: Leukopenia, Leukocytosis, Neutropenia

In brief

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders. This investigation will include a minimum of 40 sample sets from unique patients.

Key facts

Study ID

NCT06360952

Run by

Tasso Inc.

People needed

40

Starts

2024-05-31

Expected to finish

2024-08-31

Last updated by the study team

2024-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Willing and able to provide written (or electronic) informed consent prior to study entry
• At least 18 years of age
• Requiring a CBC blood test as part of the patient's standard of care
• Have abnormal laboratory results of either leukopenia, leukocytosis or neutropenia.
• Normal skin integrity and healthy skin appearance around the capillary collection site (upper arm/shoulder area on at least one side)

You may not qualify if…

• Unable to give full and free consent to participate in a study due to limited capacity or risk of undue influence or coercion (including but not limited to children, prisoners, individuals with diminished decision-making capacity, illiterate or educationally disadvantaged populations) or any other individual who is unable to give full and free consent in the judgement of the investigator
• At the determination of the treating physician, unsuitable for enrollment due to severe immunocompromised status or other comorbidities.

Where it is running

• Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.